Company Helix BioPharma Corp.

Equities

HBP

CA4229101098

Biotechnology & Medical Research

Market Closed - Toronto S.E. 09:30:00 2024-03-18 am EDT 5-day change 1st Jan Change
0.18 CAD -5.26% Intraday chart for Helix BioPharma Corp. -2.70% -14.29%

Business Summary

Helix BioPharma Corp. is a Canada-based a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47. DOS47 is an oncology platform technology that offers a potentially approach to the debilitation and destruction of cancer cells. DOS47 is designed to stimulate an increase in the Potential of Hydrogen (pH) of the microenvironment surrounding the cancerous cells, effectively reversing the acidic extra cellular conditions that are believed to act to defend the tumor. L-DOS47 is an antibody protein conjugate where the urease component enzymatically converts naturally occurring urea to ammonia. The L-DOS47 drug molecule includes a specialized camelid-derived single domain antibody and is under clinical study for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. V-DOS47 targets the vascular endothelial growth factor two recept

Number of employees: 9

Managers

Managers TitleAgeSince
Chief Executive Officer - 22-04-17
Director of Finance/CFO 59 Feb. 13
Chief Tech/Sci/R&D Officer - 22-08-31
Chief Tech/Sci/R&D Officer - 19-11-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 22-04-17
Chief Executive Officer - 22-04-17
Director/Board Member - 22-12-07
Director/Board Member - 23-08-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 216,674,415 169,754,541 ( 78.35 %) 0 78.35 %

Shareholders

NameEquities%Valuation
33,944,931 15.67 % 5 M $
3,191,600 1.473 % 450 016 $
2,083,344 0.9615 % 293 752 $
Estate of Slawomir S Majewski
0.7872 %
1,705,700 0.7872 % 240 504 $
0 0.000000 % - $

Company contact information

Helix BioPharma Corp.

401 Bay Street Suite 2704

M5H 2Y4, Toronto

+

http://www.helixbiopharma.com
address Helix BioPharma Corp.(HBP)